by Alex Khadhim
Two recent letters in Transplantation and Cellular Therapy debate how umbilical cord blood (UCB) should be positioned in modern donor-selection guidance now that post-transplant...
by Alex Khadhim
Researchers at City of Hope and Memorial Sloan Kettering Cancer Center, with collaborators from the University of Chicago, Fred Hutchinson Cancer Center, and Mayo Clinic, have found that...
by Alex Kadhim
Researchers from the European Society for Blood and Marrow Transplantation (EBMT) have found that using posttransplant cyclophosphamide (ptCy) for graft-versus-host disease (GVHD) prophylaxis in...
by Alex Kadhim
Researchers at Roswell Park Comprehensive Cancer Center and the University of Minnesota have found that targeting the pentose phosphate pathway (PPP) in donor T cells can significantly reduce the...
by Journal of Clinical Investigation
Scientists developed a conditioning protocol that, followed by allogeneic bone marrow transplantation and islet transplantation, produces a favorable mix of host and donor hematopoietic stem cells...
by Bone Marrow Transplantation
Donor traits and graft sources have a role in how outcomes play out after haploidentical hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia (ALL), report members of a...